MultiplexDx is a startup based in Slovakia, most recent round Series A, 2 tracked investors.
MultiplexDx is a company founded in 2018 headquartered in Slovakia. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
MultiplexDX develops next-generation molecular diagnostics for personalized cancer treatment. Technology can assess over 20,000 biomarkers simultaneously. EIC Accelerator recipient.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.